What Are the Wegovy Doses in Order — and How Do You Get Them in the UK?

What is the Wegovy dose schedule, from first injection to maintenance?

The titration sequence follows the order set out in the Summary of Product Characteristics published on the electronic Medicines Compendium: 0.25 mg weekly for four weeks, then 0.5 mg for four weeks, then 1.0 mg, then 1.7 mg, with each step lasting roughly a month before the next. The final step reaches 2.4 mg, which is the standard maintenance dose. If you want to understand each step in the sequence in more detail, that page walks through what happens at each level. The titration exists for a simple reason: starting at the maintenance dose tends to cause far more nausea and discomfort than the body can comfortably manage. Stepping up gradually gives the gastrointestinal system time to adapt.

One misconception worth correcting gently: some people assume the lower doses are the "real" treatment and the titration is just a formality you rush through. That is not how it works. Your prescriber decides when and whether each step is appropriate, taking your tolerance and response into account. If it helps to see how the order of dosage works across the full course, that page explains the reasoning behind each level. No step change should happen because an app nudged you or a forum said so.

For eligible adults, the MHRA approved a 7.2 mg maintenance dose in early 2026, first available as three 2.4 mg pens weekly, followed by a dedicated single-dose 7.2 mg pen approved on 14 April 2026. Whether that higher dose is right for you, and what the titration path to it looks like, is a prescriber conversation, not a product page decision. You can also follow the Wegovy steps in order to see how the full titration sequence progresses from first injection to maintenance. The Wegovy overview page covers the licensing background in full.

What is the only legal route to Wegovy in the UK?

Wegovy is a prescription-only medicine under the Human Medicines Regulations 2012. That means a prescriber must assess you and issue a prescription before any pharmacy can lawfully dispense it. There are two routes: NHS and private. On the NHS, Wegovy is available through specialist weight management services under NICE guidance (TA875), but waiting lists in many areas are long and the eligibility criteria are specific. If you'd like to understand the NHS pathway, the NHS England weight management injections page sets it out clearly.

The private route runs through a regulated online pharmacy or clinic. A prescriber reviews your consultation, and if you're clinically suitable, issues a prescription. The pharmacy then dispenses the medicine through the licensed UK supply chain. That supply chain matters: Wegovy dispensed through legitimate channels comes from Novo Nordisk's authorised distribution network. The dose schedule you receive is the licensed UK schedule, not something adapted from a forum or a foreign market.

If you want to place an order for Wegovy through a private pharmacy, the process begins with a consultation, not a basket.

How do you check that an online pharmacy is genuine?

Every pharmacy operating legally in the UK must be registered with the General Pharmaceutical Council. You can verify any pharmacy (including ours) directly on the GPhC register at registration number 9012878. That link takes you straight to our entry. It takes about thirty seconds and is worth doing for any pharmacy you consider.

The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media. Fake pens have been found to contain the wrong substances entirely, and in 2025 enforcement teams seized around 20 million doses of illegally traded weight-loss medicines, with a UK manufacturing site for counterfeit tirzepatide pens raided in Northampton. You can read the MHRA's guidance and report any suspected sellers through the Yellow Card scheme. Red flags include sellers offering Wegovy without a prior prescription, prices far below the market range, and discount codes tied to prescription medicines from unverified accounts.

More on buying Wegovy safely online (including what the legitimate process looks like from start to finish) is on that page.

Who is Wegovy licensed for, and does eligibility depend on the dose?

The UK licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The 7.2 mg maintenance dose, approved by the MHRA in April 2026, applies only to adults with a BMI of 30 or above, it is not licensed for the 27–29.9 BMI group or for the cardiovascular indication.

Eligibility is always assessed as a whole picture: BMI is a starting point, not the whole story. Pregnancy, breastfeeding, and actively trying to conceive are situations where Wegovy is not recommended; the same applies to anyone under 18. A prescriber considers your full health history before issuing any prescription, and the dose you start on reflects that assessment rather than what you've read about the schedule.

If you're unsure whether your BMI and health background fit the criteria, the guidance on lower-BMI eligibility covers the 27–29.9 bracket in detail. For a broader look at weight-loss treatment options available in the UK, that overview is a useful starting point before your consultation.